Please assess the completion status of the following clinical trial:

Trial Title: The EarLens System Long Term Safety and Efficacy Definitive Multi-Center Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Age 18 to 85 years~* Mild to severe hearing impairment between 125 to 4000 Hz~* No significant conductive hearing impairment~* Able and willing to commit to travel and time demands of the study~Exclusion Criteria:~* Must not have known or active medical issues that would preclude having a device including:~  1. an abnormal tympanic membrane~ 2. an abnormal middle ear or history of prior middle ear surgery other than tympanostomy tubes~ 3. an ear canal anatomy that prevents physicians from seeing adequate amount of the tympanic membrane~* Must not have other known or active medical issues including:~  1. history of chronic and recurrent ear infections in the past 24 mouths~ 2. history of dizziness and/or vertigo in the past 24 months~ 3. taking medications/treatments with known ototoxic effects~ 4. a rapidly progressive or fluctuating hearing impairment~ 5. having been diagnosed with having a compromised immune system~* Must not fit the definition of a vulnerable subject, as per FDA regulations 21 CFR Parts 50 and 56~* Must not have an ear canal anatomy that preclude manufacture of the device as determined by EarLens manufacturing personnel

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- Mild to severe hearing impairment (Type: EXPERIMENTAL): Sound amplification provided via the EarLens System assistive hearing device.

Based on this trial design, predict the completion outcome and termination type (if applicable).